Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2018 Mar-2017 Mar-2016 Mar-2015
Growth matrix (%)        
Revenue growth 18.90 (24) (13) (47)
Op profit growth (12) (1,225) (103) (177)
EBIT growth (13) 276 (111) 42.40
Net profit growth (13) 38.70 (327) 340
Profitability ratios (%)        
OPM (6.60) (8.90) 0.61 (18)
EBIT margin (10) (14) (2.80) 22.90
Net profit margin (22) (30) (16) 6.32
RoCE (7.20) (6.60) (1.60) 13.60
RoNW (10) (9.70) (5.40) 2.20
RoA (3.90) (3.60) (2.40) 0.94
Per share ratios ()        
EPS -- -- -- 3.33
Dividend per share -- -- -- --
Cash EPS (8.80) (13) (10) 0.10
Book value per share 16 22.90 31 38.50
Valuation ratios        
P/E -- -- -- 8.92
P/CEPS (3.20) (2.30) (3) 289
P/B 1.75 1.29 0.97 0.77
EV/EBIDTA (25) (29) 53.50 4.28
Payout (%)        
Dividend payout -- -- -- --
Tax payout 14.90 (4.40) (1.20) 1.71
Liquidity ratios        
Debtor days 185 342 335 348
Inventory days 64.80 93 69.50 81.30
Creditor days (116) (159) (172) (133)
Leverage ratios        
Interest coverage 1.12 0.77 0.18 (1.70)
Net debt / equity 1.15 1.87 1.35 0.92
Net debt / op. profit (8.60) (14) 151 (3.70)
Cost breakup ()        
Material costs (50) (80) (77) (84)
Employee costs (9.70) (10) (8.20) (11)
Other costs (47) (19) (14) (23)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2018 Mar-2017 Mar-2016 Mar-2015
Revenue 77.20 65 85.30 97.70
yoy growth (%) 18.90 (24) (13) (47)
Raw materials (38) (52) (66) (82)
As % of sales 49.60 79.90 77.40 83.60
Employee costs (7.50) (6.80) (7) (11)
As % of sales 9.68 10.50 8.19 11
Other costs (37) (12) (12) (23)
As % of sales 47.30 18.50 13.80 23.40
Operating profit (5.10) (5.80) 0.52 (18)
OPM (6.60) (8.90) 0.61 (18)
Depreciation (4) (4.20) (4.90) (6)
Interest expense (6.90) (11) (13) (13)
Other income 1.29 1.14 1.98 46
Profit before tax (15) (20) (15) 8.90
Taxes (2.20) 0.90 0.18 0.15
Tax rate 14.90 (4.40) (1.20) 1.71
Minorities and other -- -- 1.11 --
Adj. profit (17) (19) (14) 9.01
Exceptional items -- -- -- (2.80)
Net profit (17) (19) (14) 6.18
yoy growth (%) (13) 38.70 (327) 340
NPM (22) (30) (16) 6.32
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2018 Mar-2017 Mar-2016 Mar-2015
Profit before tax (15) (20) (15) 8.90
Depreciation (4) (4.20) (4.90) (6)
Tax paid (2.20) 0.90 0.18 0.15
Working capital (62) (54) (34) --
Other operating items -- -- -- --
Operating cashflow (83) (78) (54) 3.07
Capital expenditure (8.60) (6.30) (11) --
Free cash flow (91) (84) (65) 3.07
Equity raised 81.90 92.30 103 100
Investments -- 16.90 16.90 --
Debt financing/disposal (39) (18) (28) --
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash (48) 6.92 28 103
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2018 Mar-2017 Mar-2016 Mar-2015
Equity capital 23.70 22.70 18.70 18.70
Preference capital -- -- -- --
Reserves 14.30 20 39.10 53.10
Net worth 37.90 42.70 57.80 71.80
Minority interest
Debt 46.50 82.40 80.50 68.70
Deferred tax liabilities (net) 5.11 2.92 3.82 4
Total liabilities 88.90 127 142 145
Fixed assets 44.90 48.60 52.60 54.60
Intangible assets
Investments -- 16.90 16.90 16.90
Deferred tax asset (net) -- -- -- --
Net working capital 41 59.30 69.80 71.10
Inventories 10.70 16.70 16.40 16.10
Inventory Days 50.40 94.10 70.10 60.20
Sundry debtors 24.30 53.80 68 88.70
Debtor days 115 302 291 331
Other current assets 55.60 39.60 36.10 20.80
Sundry creditors (29) (24) (38) (42)
Creditor days 135 134 161 158
Other current liabilities (21) (27) (13) (12)
Cash 2.95 2.66 2.71 2.77
Total assets 88.90 127 142 145
Switch to
Consolidated
Standalone


Bafna Pharmaceuticals Ltd Report not showing data